RETRACTED: Godugu et al. Anti-Cancer Activities of Thyrointegrin &#945;vß3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780.

Godugu, Kavitha; Rajabi, Mehdi; Mousa, Shaker A

RETRACTED: Godugu et al. Anti-Cancer Activities of Thyrointegrin α_vß₃ Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780.

Godugu, Kavitha; Rajabi, Mehdi; Mousa, Shaker A.

Afiliação

Godugu K; The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12208, USA.
Rajabi M; The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12208, USA.
Mousa SA; The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12208, USA.

Cancers (Basel) ; 16(10)2024 May 15.

Article em En | MEDLINE | ID: mdl-38792024

ABSTRACT

ABSTRACT

The journal retracts the article, "Anti-Cancer Activities of Thyrointegrin αvß3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma" [...].

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google